The aim of this study was to establish hepatocyte isolation in pigs, and to evaluate function of isolated hepatocytes after encapsulation, cryopreservation, and transplantation (Tx) in a mouse model of fulminant liver failure (FLF). After isolation, porcine hepatocytes were microencapsulated with alginate-poly-L-Lysinealginate membranes and cryopreserved. In vitro, albumin production of free and encapsulated hepatocytes were measured by enzyme linked-immunoadsorbent assay. In vivo, encapsulated hepatocytes were transplanted into different groups of mice with FLF and the following experimental groups were performed: group 1, Tx of empty capsules; group 2, Tx of free primary porcine hepatocytes; group 3, Tx of fresh encapsulated porcine hepatocytes; group 4, Tx of cryopreserved encapsulated porcine hepatocytes. In vitro, fresh or cryopreserved encapsulated porcine hepatocytes showed a continuous decreasing metabolic function over 1 week (albumin and urea synthesis, drug catabolism). In vivo, groups 1 and 2 showed similar survival (18% and 25%, respectively, p > 0.05). In groups 3 and 4, Tx of fresh or cryopreserved encapsulated porcine hepatocytes significantly increased survival rate to 75% and 68%, respectively (p < 0.05). Primary porcine hepatocytes maintained metabolic functions after encapsulation and cryopreservation. In mice with FLF, Tx of encapsulated xenogeneic hepatocytes significantly improved survival. These results indicate that porcine hepatocytes can successfully be isolated, encapsulated, stored using cryopreservation, and transplanted into xenogeneic recipients with liver failure and sustain liver metabolic functions.
INTRODUCTION
(7, 8, 17, 36) . However, the shortage of organ donors also limits the availability of human hepatocytes. It is therefore essential to find new sources of tissues for Tx. Liver transplantation (Tx) is the most effective therapy for acute or chronic hepatic failure, but shortage of Tx of xenogeneic hepatocytes has been considered as unlimited availability of cells to treat liver diseases organ donors limits its application. Alternative therapies for the treatment of liver failure are under investigation (4, 26) . Recently, porcine hepatocytes have been used clinically in bioartificial livers (BAL) (13). As immune and several approaches are currently tested: (i) extracorporeal hybrid bioartificial liver devices (22, 28) , (ii) im-responses are still major barriers for successful cell and organ xenotransplantation, semipermeable capsules us-plantable bioartificial liver devices (6, 9, 10) , and (iii) hepatocyte transplantation (1, 7, 8, 16, 17, 21, 36, 37, 39) .
ing polymers have been developed to protect xenogeneic cells (2, 11) . The small pores of the capsules prevent Hepatocyte allotransplantation has been used successfully in rodent (16, 21, 37) and primates (1, 39) as therapy cells and antibodies to cross, while oxygen, glucose, and nutrients can pass through the membranes and maintain of chronic or acute liver failure. In humans, studies showed that hepatocyte allotransplantation was useful metabolic functions. However, long-term survival of encapsulated cells has been disappointing, preventing its for bridging patients to whole organ Tx, for providing metabolic support during acute liver failure, or for re-clinical use.
The aim of the present study was to test in vitro and placing whole organ Tx in metabolic liver diseases 102 MEI ET AL. in vivo the function of primary porcine hepatocytes af-Williams E medium (Invitrogen) for assessment of albumin secretion. ter isolation, microencapsulation, cryopreservation, and xenotransplantation in a mouse model of fulminant liver Evaluation of Metabolic Function failure (FLF) established by acetaminophen administration followed by a 30% hepatectomy.
Porcine hepatocytes (primary freshly isolated or immortalized, free or encapsulated) were cultured in se-
MATERIALS AND METHODS
rum-free Williams Medium E (Invitrogen) and incu-Animals bated at 37°C for 1 week. Culture medium was collected every day and stored at −20°C for assessment of albu-Three-month-old male pigs (n = 5) (Centre Medical min secretion by enzyme-linked immunosorbent assay Universitaire, Geneva, Switzerland) and weighing [10] [11] [12] [13] [14] [15] (ELISA; Bethyl, Lucerne, Switzerland). kg were used as donors of hepatocytes. Eight-to 10-To analyze urea synthesis and drug catabolism, amweek-old adult male C57BL/6 mice (Charles River Labmonium sulfate (0.56 mM), lidocaine (1 mg/ml), or dioratories, France), weighing 25-30 g, were used as azepam (1 µg/ml) was added to the culture medium at recipients. Animals were maintained in conventional 1, 3, and 7 days after seeding 5 × 10 4 hepatocytes in housing facilities and experimental protocols were apeach well of a 24-well plate. After 6 h, concentrations proved by the ethical committee of the Geneva Univerof each reagent and urea, a metabolite of ammonium sity Medical School and by Geneva veterinary authoricatabolism, were measured and compared between the ties.
groups. The measurements were performed by the clini-Isolation of Porcine Hepatocytes cal chemistry unit of Geneva University Hospital using Cobas INTEGRA 400 (Roche Diagnostic, Basel, Swit-Under general anesthesia, a midline laparotomy was zerland) and DxC 800 system (Beckman Coulter Inc., performed and the liver was exposed. After ligation of Brea, CA, USA). blood vessels at the root of the lateral lobe of the liver, the left lateral lobe was perfused with cold Viaspan Encapsulation of Porcine Hepatocytes (Bristol Meyers Squibb, Baar, Switzerland). The per-Isolated porcine hepatocytes were centrifuged at 50 × g fused liver lobe was subsequently explanted and put on for 5 min and the pellet was suspended in sterile MOPS ice for the following steps of oxygenated perfusion. The washing-buffer solution (10 mM MOPS + 0.85% NaCl, oxygenated perfusion was started at a rate of 60 ml/min Inotech, Dottikon, Switzerland) and mixed with 1.5% for 15 min, using a warm (37°C) oxygenated perfusion sodium-alginate solution (Inotech). Encapsulation was Ca 2+ -free buffer [Hepatocyte Liver Perfusion Medium performed using an encapsulation device (Encapsulator, (1×), Invitrogen, Basel, Switzerland]. The liver tissue Inotech), where the porcine hepatocyte-alginate suspenwas then perfused with collagenase solution (37°C) sion flowed through a 200-µm nozzle and was mixed [Liver Digest Medium (1×), Invitrogen] at a rate of 60 with a polymerization solution (10 mM MOPS + 100 ml/min for 10 min. Hepatocytes were released by minc-mM CaCl 2 , Inotech) to hepatocyte beads. Poly-L-lysine ing and shaking the liver in a petri dish containing cold (PLL) hydrobromide solution 0.05% (Sigma-Aldrich L-15 Medium (Invitrogen) 10% FBS (Invitrogen). The GmbH) was added to the hepatocyte beads to form a cell suspension was filtered through a sterile 100-µm PLL-alginate membrane. Then, the beads were imnylon mesh into a beaker. Porcine hepatocytes were mersed in a 0.03% alginate solution (Inotech) to form washed in cold Hepatocyte Wash Medium (Invitrogen) the outer alginate membrane. After washing, the beads and purified by 60% Percoll (Amersham Biosciences were put into a depolymerization solution (50 mM Na 3 AB, Uppsala, Sweden) density gradient separation and citrate, 10 mM MOPS + 0.45% NaCl, Inotech) to disresuspended for culture and encapsulation. Finally, viasolve the core alginate, transforming beads into alginatebility was determined by trypan blue exclusion test PLL-alginate capsules of a mean diameter of 400 µm (5) (32,33).
( Fig. 1 ). Capsules were cultured in serum-free Williams
Primary Culture of Porcine Hepatocytes in Monolayers
Medium E (Invitrogen) or incubated in Hank's solution (University Hospital of Geneva, Geneva, Switzerland) Cells were cultured on 12-well Primaria plates (Falcon) at 2.5 × 10 5 cells/well, in Williams E medium (In-for cryopreservation or Tx. vitrogen), with 10% FBS (Invitrogen), penicillin (100 Cryopreservation of Encapsulated Porcine Hepatocytes U/ml)/streptomycin (100 µg/ml) (Invitrogen), insulin (10 −7 M)( Huminsulin, Lilly France S.A.S, Strasbourg, After addition of 10% DMSO (v/v) (Merck, Darmstadt, Germany) and 10% FBS (Invitrogen) to Williams France), dexamethasone (10 −6 M) (Sigma-Aldrich GmbH, Basel, Switzerland), EGF (25 ng/ml) (Sigma-E culture medium, cell suspensions of freshly isolated and encapsulated porcine hepatocytes were transferred Aldrich GmbH). Next day, we switched to serum-free into 2-ml cryogenic tubes at 1 × 10 7 cells/ml and placed pended in 3 ml Hank's through an 18-gauge needle into the abdomen cavity at the end of 30% hepatectomy. in the freezing chamber of a programmable freezing unit (Kryo 10 series III, Planer, UK) for cryopreservation
The following experimental groups were defined: group 1 (n = 11) Tx of empty capsules; group 2 (n = 12) and frozen using a computerized rate-controlled freezing program. Briefly, the sample temperature was reduced Tx of free primary porcine hepatocytes; group 3 (n = 36) Tx of encapsulated porcine hepatocytes; group 4 at 1°C/min from 4 to 0°C, then reduced at 0.5°C/min from 0 to −11°C, kept at −11°C for 15 min, and then (n = 38) Tx of cryopreserved encapsulated porcine hepatocytes. reduced at 3°C/min from −11 to −80°C. Finally, the cryogenic tubes were stored in liquid nitrogen for 10
Survival Follow-up and Histology days. The encapsulated porcine hepatocytes were rapidly thawed by immersing the cryogenic tubes in a 37°C wa-In each group, mouse survival was followed up at terbath (<1 min), and the encapsulated hepatocytes were different time points, two animals were euthanized at gently washed by sedimentation three times with Hank's regular intervals (i.e., 2 weeks and at 1 month post-Tx), solution. One portion of encapsulated hepatocytes were and histopathology of microcapsules and liver tissues resuspended in supplemented serum-free Williams E were performed. culture medium, as specified above, and incubated at Statistical Analysis 37°C in 5% CO 2 for 7 days.
Statistical analysis was performed using STATIS-Induction of Fulminant Liver Failure TICA (STATISTICA 5.5 Software for Windows, Statsoft Inc, Tulsa, OK). Survival curves were calculated by A model of fulminant liver failure was established in Kaplan-Meier method and analyzed with chi-square test. C57/BL6 mice by acetaminophen administration (700 A value of p < 0.05 was considered statistically signifimg/kg, IP) followed 15 h later by a 30% hepatectomy, cant. as previously described (19, 27) .
RESULTS

Experimental Groups and Transplantation of Encapsulated Hepatocytes Viability
We isolated 8.05 × 10 6 ± 1.86 × 10 6 porcine hepato-We performed the intraperitoneal Tx by injecting >50 × 10 6 free or encapsulated porcine hepatocyte sus-cytes per gram of liver tissue. Cell viability was mea- sured after isolation at 76 ± 8%, after encapsulation at Evaluation of Metabolic Function 67 ± 7% and after cryopreservation at 54 ± 5%. Viability after encapsulation and cryopreservation was evalu-Porcine hepatocytes under various conditions (free or encapsulated, fresh or cryopreserved) showed a continu-ated on the surface of cell aggregates, but we could not evaluate their centers. ous decrease of albumin and urea synthesis and drug catabolism (lidocaine and diazepam) over the first week treated mice (p > 0.05). In groups 3 and 4, Tx of freshly isolated or cryopreserved encapsulated porcine hepato-of culture (Fig. 2) . The values reported in Figure 2A and B represent the appearance of albumin and urea in the cytes significantly increased survival rate to 75% and 68%, respectively (p < 0.01) ( Fig. 3 ). culture medium synthesized by porcine hepatocytes. The values reported in Figure 2C -E represent ammonium Histopathology sulfate, diazepam, and lidocaine clearance of the culture media. Thus, an increase of drug concentration over Histopathology of native liver tissue demonstrated massive hemorrhage and extensive hepatocyte necrosis time represents a decrease of hepatocyte catabolism.
There was no significant difference in albumin and at 15 h after acetaminophen administration (Fig. 4A) . In contrast, surviving mice showed complete recovery of urea synthesis or drug catabolism over time for the three conditions of porcine hepatocytes (free primary hepato-native liver tissue 2 weeks post-Tx (Fig. 4B) . At 1-month post-Tx, histopathological examination cytes, fresh encapsulated, and cryopreserved encapsulated hepatocytes ( Fig. 2A-E) .
showed fibrosis on the surface of transplanted capsules surrounded by inflammatory cells (Fig. 5) . In Vivo Studies DISCUSSION FLF was achieved by combination of acetaminophen and 30% hepatectomy, resulting in a survival of approxi-Liver allotransplantation is considered the only effective therapy for severe hepatic disorders, such as fulmi-mately 20%. In groups 1 and 2, survival remained unmodified (18% and 25%, respectively), compared to un-nant liver failure (FLF), where need for adequate ther-apy is required urgently and liver or cell Tx must be cytes when transplanted in a rat model of acute liver failure induced by a two-stage 95% hepatectomy (3,30, performed within hours. Therefore, a method of hepatocyte storage must be developed, as preparation of encap-31). Other groups have used porcine hepatocytes to improve liver function and prolong the survival of rats with sulated primary is time consuming.
Kunieda et al. reported that cryopreservation using cirrhosis (24, 35) . We are not aware of other studies using cryopreservation and microencapsulation of porcine UW solution allows storage of rat hepatocytes long term to make best use of available hepatocytes (15). Hengstler hepatocytes for therapy of fulminant liver failure in a mouse model, which is close to clinical situations. et al. showed that cryopreserved human hepatocytes demonstrated a high cell viability and over 60% cytochrome For our mouse model, we started to administrate an overdose of acetaminophen alone to induce fulminant P450 activity when compared to freshly isolated hepatocytes (12) . Thus, cryopreservation provides an easy, low-hepatic failure. We observed a high variability in the mortality of animals with an on-off response. Combina-cost method for preserving hepatocytes with maintenance of good viability and could play an important role in cell tion of acetaminophen followed by 30% hepatectomy induced a stable mortality around 80% (19, 27) . There-Tx or therapy for fulminant hepatic failure.
In our study, we tested the in vitro function of por-fore, this model results in a similar mortality as observed clinically in patients with fulminant hepatic failure. In cine hepatocytes after isolation, encapsulation, and cryopreservation. Over 1 week in culture, decreasing albu-the literature, few studies have used a model of acute liver failure induced by acetaminophen alone in a trans-min and urea synthesis, as well as drug catabolism (diazepam and lidocaine), were observed for porcine he-plant setting (38). This model was mainly used to study toxicology and pharmacology of acetaminophen (34) . patocytes, regardless if the cells were freshly isolated, free, encapsulated, or cryopreserved ( Fig. 2A-E) . These An alternative animal model of acute liver failure is the 90% hepatectomy, but is usually performed in rats (23). results are in accordance with several studies showing that free primary hepatocytes are difficult to maintain One research group has used this 90% hepatectomy model in mice and reported that all animals died within in culture (14, 18, 25) . Interestingly, encapsulated porcine hepatocytes, fresh or cryopreserved, demonstrated a 24 h after hepatectomy (20) . In conclusion, our model combining acetaminophen followed by a 30% hepatec-higher albumin secretion at 1 week of culture, compared to free primary hepatocytes ( Fig. 2A) . This result sug-tomy induced a stable mortality of 80%, which is similar to the clinical situation. gests that capsules represent an appropriate environment for maintenance of biological functions.
Histopathology of liver tissue showed massive hemorrhage and extensive hepatocyte necrosis at 15 h after In vivo, intraperitoneal Tx of empty capsules (group 1) or free primary porcine hepatocytes (group 2) did not acetaminophen administration (Fig. 4A ). After 2 weeks, histopathological examination showed that surviving improve survival of mice with FLF, indicating a rapid loss of transplanted cells, possibly due to innate or hu-mice had a complete recovery of native liver tissue ( Fig.  4B) . At 1 month after Tx, histology showed fibrosis for-moral rejection mechanisms.
In contrast, Tx of encapsulated fresh porcine hepato-mation on the surface of microcapsules that were surrounded by inflammatory cells (Fig. 5 ). This fibrosis cytes (group 3) significantly increased survival of mice with FLF from 20% to 75% (p < 0.01), indicating that clearly indicates that the capsule material used in these experiments would not be appropriate for treatment of encapsulation protects hepatocytes from recipient immune responses. chronic liver diseases. However, the function of encapsulated cells was sufficient to allow regeneration of na-Tx of cryopreserved encapsulated cells (group 4) similarly improved survival from 20% to 68% (p < tive liver tissue.
In conclusion, the data presented in this study indi-0.01), demonstrating that cryopreservation did not significantly alter hepatocyte function (Fig. 3) .
cate that xenogeneic porcine hepatocytes can be isolated, encapsulated, and cryopreserved and still maintain Other authors have used Tx of xenogeneic hepatocytes in animal models of acute liver failure. Roger et biological functions in vitro. When transplanted intraperitoneally, fresh or cryopreserved encapsulated xeno-al. introduced porcine hepatocytes in hollow fibers protected by a semipermeable membrane and transplanted geneic porcine hepatocytes provided life-supporting liver-specific metabolic functions for a short period of these intraperitoneally into rats with acute liver failure induced by 95% hepatectomy. Survival rate was in-time and allowed regeneration of native liver tissue without immunosuppressive therapy. These findings creased from 27% in controls to 64% in treated animals (29) . More recently, Sarkis et al. and Benoist et al. have great potential for clinical use, as encapsulated xenogeneic could be easily stored as described here and showed that macroencapsulated cryopreserved porcine hepatocytes were as effective as freshly isolated hepato-injected intraperitoneally in patients with FLF.
